Peripheral opioid receptor

"Peripheral opioid receptors" refer to classical opioid receptors—primarily the mu-, delta-, and kappa-opioid receptors—that are located outside the central nervous system, such as on sensory nerve endings in peripheral tissues and immune cells. These G protein-coupled receptors mediate analgesic effects when activated by endogenous peptides or exogenous drugs but do so without causing typical central side effects like sedation or respiratory depression when targeted selectively in the periphery. Therapeutic strategies have focused on developing peripherally restricted agonists and antagonists to maximize beneficial actions such as pain relief or mitigation of gastrointestinal side effects while minimizing abuse potential and other CNS-mediated adverse events[1][3][4][6]. The term itself is not a precise molecular target but describes a pharmacological approach based on tissue distribution; thus it should be mapped more specifically to individual subtypes like "Mu-opioid receptor," specifying their peripheral localization where relevant.

Other names

Peripherally expressed opioid receptorsPeripheral mu-opioid receptorPeripheral kappa-opioid receptorPeripheral delta-opioid receptor

Agonists activate peripheral opioid receptors on sensory neurons or immune cells to inhibit pain signaling and reduce inflammation. Antagonists block peripheral effects of opioids without affecting central analgesia. Peripherally restricted drugs minimize CNS side effects by limiting blood-brain barrier penetration